Can an old dog do new tricks ? When U is first Advertising software to get Truste Stamp of Approval February 15, 2007
Posted by Mark Blei in : Uncategorized , trackbackWhenU Save products awarded certification as safe and consumer-controlled downloadable software; TRUSTe download guidelines to set industry standard
NEW YORK – February 15, 2007 – Behavioral ad targeting company, WhenU.com, today announced that its Save products are the first “Certified Advertising Software” to be whitelisted by TRUSTe’s Trusted Download Program. TRUSTe, the leading online privacy certification organization, partnered with AOL, Computer Associates, CNET, Microsoft, Verizon, and Yahoo! to establish strict guidelines for downloadable software and a certification program for software applications which meet these guidelines.
The Trusted Download Program offers a whitelist for businesses to direct advertising dollars and partnership opportunities only to safe software requiring informed user consent and control. WhenU’s Save applications became TRUSTe’s first Certified Advertising Software after demonstrating an ongoing commitment to industry best practices.
“WhenU continues to be one of the strongest industry proponents of consumer control and download transparency,” said Bill Day, CEO of WhenU. “With the increasing popularity of downloadable software and advertising supported software and services, it is essential to establish industry guidelines to protect consumers, publishers and advertisers and enable then to make smart decisions about whom to do business with. It’s a historic moment as there is now a definitive certification process to guide the regulation of downloadable software.”
The lack of a third party certification program in the past has led to considerable variance in business practices and consumer confusion in the downloadable software space. As part of its mission, the Trusted Download Program will identify and elevate trustworthy applications and, in doing so, enable online advertisers to protect valued brands.
Comments»
no comments yet - be the first?